- Pfizer grabs another breakthrough tag for RSV shot in older adults
- From whiteboard to white coat: Roivant Social Ventures teams up with San Diego drug discovery center to bolster diversity in biopharma
- Hookipa CEO waives 50% of salary in bet on brighter days
- Sponsored: Bridging the preclinical to clinical divide: practical considerations for biomarker success
- Homology gets clarity on how to resolve pheNIX gene therapy hold
- Sponsored: Unlocking the power of AI-driven pathology in drug development: An Interview with Bristol Myers Squibb
- Ligand takes a crack at a SPAC to buoy spun-off antibody discovery business
- Orion staff brace for layoffs, program terminations after cancer and pain emerge as R&D stars
- Another Eylea rival struggles in phase 2, this time fielded by Ribomic
- Celsius turns up the heat with lead drug selection, $83M financing
- As Russian invasion persists, Roche, Teva, Novartis, Merck and more make renewed push to support besieged Ukraine
- Celltrion's rapid COVID tests hit with 2nd Class I recall in a month
- Could a simple dietary supplement treat Alzheimer's?
- Eli Lilly, Innovent hit with FDA rejection for China-developed lung cancer drug after tough review
- #FierceMadness: Boudreaux, Brooks-LaSure narrowly advance to Sweet 16
- #FierceMadness: BMS' Zeposia, Gilead's Trodelvy and Lilly's Retevmo advance to Sweet 16 as Horizon's Tepezza wins big
Featured Story | By Annalee Armstrong Pfizer’s respiratory syncytial virus (RSV) program is piling on the wins. After gaining a breakthrough tag for its maternal vax program earlier this month, the New York pharma added the same designation for prevention of RSV in older adults. read more |
| |
|---|
|
Top Stories By Max Bayer Roivant Social Ventures is partnering with San Diego-based drug discovery center Sanford Burnham Prebys to launch a new Ph.D. program designed to bolster diversity in biopharma. The program aims to provide hands-on training in all aspects of drug development, from discovery to clinical trials. read more By Nick Paul Taylor Hookipa Pharma CEO Joern Aldag is betting on brighter days for biotech. With Hookipa’s stock stuck in the doldrums, Aldag is waiving 50% of his salary over the first half of the year in return for shares in a show of confidence in the company. read more Sponsored by: Precision for Medicine To successfully advance preclinical biomarker assays from the bench to the bedside, it is crucial to develop a clear plan for delivering assays that can be used within the clinical trial setting. Learn strategies for assessing and optimizing biomarker feasibility and utility to support study success. read more By Annalee Armstrong Homology Medicines is adding an immunosuppressive regimen to a phase 1/2 trial for its phenylketonuria gene therapy, hoping to quell FDA concerns that triggered a clinical hold in February. read more Sponsored by: PathAI Learn how Bristol Myers Squibb is unlocking new insights in translational research and development by transforming pathology with artificial intelligence read more By Max Bayer Ligand Pharmaceuticals was ready to spin off its antibody discovery wing into a new company when special purpose acquisition company Avista Public Acquisition Corp. came knocking. read more By Nick Paul Taylor Orion is hunting for opportunities to slim down its R&D unit. The Finnish drug developer plans to refocus the operation on cancer and pain, leading to the cessation of investment in rare and neurodegenerative diseases and the departures of up to 37 employees. read more By Annalee Armstrong Another attempt to take on Regeneron and Bayer's juggernaut Eylea is struggling in the clinic. This time, it’s Ribomic’s wet age-related macular degeneration therapy RBM-007. read more By Sophia Sorensen The temperature is rising at Celsius Therapeutics as the precision-medicine-focused biotech picks a lead candidate and reels in $83 million in funding. read more By Fraiser Kansteiner Swiss pharma Roche on Wednesday said it was donating additional drugs and diagnostics to Ukraine. It's one of many drugmakers making new or renewed pushes to support the country as the war with Russia drags on. read more By Andrea Park Celltrion’s range of COVID-19 test kits is once again under the FDA’s microscope this month, weeks after the regulator cracked down on sales of a version of Celltrion’s rapid antigen test that has been cleared only in the E.U. and another that was cleared in the U.S. but has been associated with a higher-than-average rate of false positives. read more By Max Bayer New research out of Indiana University suggests vitamin B3, also known as niacin, could have the potential to treat Alzheimer's. The scientists found improved working memory and a reduction in amyloid plaques among mice treated with a prescription form of the supplement. read more By Angus Liu The other shoe has dropped for Eli Lilly and Innovent Biologics’ bid to introduce a China-developed cancer immunotherapy to the U.S. market. read more By Paige Minemyer This year, Fierce Healthcare's #FierceMadness is back, and we want you to help us identify the industry's most influential person. read more By Ben Adams It’s March, so it’s time for some #FierceMadness. We’re looking for the best of the best in drug names—and this round we saw wins for Bristol Myers, BioMarin, Gilead, Eli Lilly and more, as AstraZeneca and Takeda drugs dropped out. Now it's time to get voting for your Elite 8. read more Resources Sponsored by: H1 Read why many MSLs are still challenged in developing integrated strategies to increase the volume of meaningful engagements. Download this industry report to find out what the top challenges are and suggestion strategies to solve them. Download now. Sponsored by: Medidata, a Dassault Systèmes company The landscape of clinical trials has been permanently changed. Today's trials require sponsors to modernize their use of technology and data to adapt. This eBook provides an overview of how sponsors can empower trials with real-time performance data to improve study integrity, reduce risks, optimize patient safety, and increase trial success rates. Sponsored by: Thermo Fisher Scientific Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow. Sponsored by: Oracle Health Sciences How to overcome top challenges faced in decentralized trials. Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Fierce Promotional Review Committee Compliance and Best Practices Summit April 12-14, 2022 | New Brunswick, NJ Accelerating Immuno-Oncology and Oncology Drug Development Using Humanized Mice Live & Recorded on: Thursday, April 21, 2022 | 12pm ET / 9am PT Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Promotional Review Committee Compliance and Best Practices Summit West (PRC West) September 2022 | San Diego, CA Medical Affairs Strategic Summit (MASS West) September 2022 | San Diego, CA Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce Pharma Marketing Awards October 19, 2022 | Philadelphia, PA Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce European Trial Master File Summit November 14-16, 2022 | London, UK Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 
